MCP-1-Induced Histamine Release from Mast Cells Is Associated with Development of Interstitial Cystitis/Bladder Pain Syndrome in Rat Models
Authors:
Open Access
- 19 September 2012
- journal article
- research article
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2012, 1-9
Abstract
Objective. Interstitial cystitis/bladder pain syndrome (IC/BPS) is characterized by overexpression of monocyte chemoattractant protein-1 (MCP-1) in bladder tissues and induction of mast cell (MC) degranulation. This study was undertaken to explore the mechanism of action of MCP-1 in the development of IC/BPS. Methods. A rat model of IC/BPS was developed by perfusing bladders of nine SPF- grade female Sprague-Dawley rats with protamine sulfate and lipopolysaccharide (PSKeywords
This publication has 28 references indexed in Scilit:
- Renin released from mast cells activated by circulating MCP-1 initiates the microvascular phase of the systemic inflammation of alveolar hypoxiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Mast Cell PeptidasesAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitisBMC Genomics, 2009
- Mast Cell-Derived Histamine Mediates Cystitis PainPLOS ONE, 2008
- Mast cell tryptases and chymases in inflammation and host defenseImmunological Reviews, 2007
- Epidemiology of interstitial cystitisUrology, 1997
- Bladder Injury Model Induced in Rats by Exposure to Protamine Sulfate Followed by Bacterial EndotoxinJournal of Urology, 1996
- Activation of Bladder Mast Cells in Interstitial Cystitis: A Light and Electron Microscopic StudyJournal of Urology, 1995
- Activation of Bladder Mast Cells in Interstitial CystitisJournal of Urology, 1995
- Pathology and Pathophysiology of Painful Bladder DiseasesUrologia Internationalis, 1989